ArabicArabicFrenchFrenchSpanishSpanishRussianRussianGermanGermanItalianItalianJapaneseJapaneseKoreanKoreanPortuguesePortugueseHindiHindiRomanianRomanianPolishPolishThaiThaiEnglishEnglish

info@errason.com

Facebook
Twitter
Youtube
LinkedIn
Pinterest

Nanjing Errason Biological Technology Co.,Ltd
  • Home
  • About us
  • Products
    • poultry plastic bottle
    • Sterilizing Equipment
      • ES-100 Portable Vaporized Hydrogen Peroxide Decontamination Instrument
      • ES PRO Sterilizing Robot
    • Pharmaceutical Raw material
    • Veterinary instruments
    • Medical device
    • Veterinary
    • Chemical
    • Medicinal bottle
      • Liquid medicinal bottles
      • Cream container
      • Examine apparatus
      • Vagina Applicator
      • Enema bottle
      • Eye drop bottles
      • Solid medicinal bottles
      • Spraying medicinal bottles
      • Oral liquid bottles
    • Health food
    • Cosmetic ingredients
  • News
    • Company news
    • Industry-news
  • Global partners
  • solution
    • Principle of hydrogen peroxide vapour disinfection systems
  • Feedback
  • Contact us
  1. Home
  2. Products
  3. Pharmaceutical Raw material
  4. Rivaroxaban CAS 366789-02-8

Rivaroxaban CAS 366789-02-8

  • Product Item:CAS 366789-02-8
  • CAS 366789-02-8
  • MF:C19H18ClN3O5S
  • Appearance:White to yellowish powder, odorless, non-hygroscopic
  • Purity(by HPLC):≥99.90%
  • Rivaroxaban  , 366789-02-8  , C19H18ClN3O5S
    Inquiry Send Email

    Description

    Introduction:
    Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible
    Function  :
    Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valvedisease, and at least one additional risk factor for stroke (congestive heart failure, hypertension, age, diabetes, and prior stroke)
    Rivaroxaban can also be used to prevent the formation of blood clots in the veins (deep venous thrombosis) in adults who have had an operation to replace a hip or knee and for treatment and prevention of acute deep venous thrombosis in adults. It can not be used for prevention of venous thrombosis in hospitalized medically ill patients.
    Rivaroxaban is not indicated for prosthetic heart valves or for mitral stenosis.
    Rivaroxaban is not indicated as an add-on treatment for dual antiplatelet therapy in the secondary prevention of coronary incidents (double and triple therapy). In Europe, however, a 2.5-mg twice-daily dose was approved by the European Commission after a recommendation by the European Medicines Agency (EMA) for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine.
    Items Standards Results
    Appearance White to yellowish powder, odorless, non-hygroscopic Complies
    Identification By IR Complies
    By HPLC Complies
    Solubility Slightly soluble in acetone and PEG 400, and practically insoluble in water, ethanol and aqueous media, soluble in chloroform, DMSO(87 mg/ml at 25ºC) Complies
    Polymorphism Polymorph form 1 Complies
    Melting Point  228.0~231.0ºC 228.2~229.8ºC
    Loss on Drying ≤ 0.50% 0.30%
    Heavy Metals ≤ 10ppm Complies
    Residue on Ignition ≤ 0.10% 0.08%
    Sulfate ≤0.05% Complies
    Enantiomeric Impurity ≤ 0.10% 0.00%
    Related Substance Any individual impurity: ≤0.10% 0.06%
    Total impurities: ≤0.50% 0.10%
    Purity(by HPLC) ≥ 99.5% 99.90%
    Particle Size D90: ≤200µm Complies
    Reference Standard In-house Standard
    Conclusion The product complied to In-house standard.
    Storage Preserve in tight,light-resistant containers in a cool place

    Inquiry Us





    Related Products

    procaine hydrochloride 0.02% 100ml injection

    procaine hydrochloride 0.02% 100ml injection

    White Plastic Medicine Bottle 20ml Round Bottle

    White Plastic Medicine Bottle 20ml Round Bottle

    Nucleotide CAS 4691-65-0   5550-12-9

    Nucleotide CAS 4691-65-0 5550-12-9

    Top Sale Pet 10ml Clear Blue Flat Plastic Eye Drop Bottle PET Liquid Bottle Container

    Top Sale Pet 10ml Clear Blue Flat Plastic Eye Drop Bottle PET Liquid Bottle Container

    High Quality HDPE 25ml Plastic Medicine Liquid Plastic Applicator Bottle with Cap

    High Quality HDPE 25ml Plastic Medicine Liquid Plastic Applicator Bottle with Cap

    10ml Plastic Bottles Eliquid Eye Drop Bottle

    10ml Plastic Bottles Eliquid Eye Drop Bottle

    Product Categories

    • poultry plastic bottle
    • Sterilizing Equipment
      • ES-100 Portable Vaporized Hydrogen Peroxide Decontamination Instrument
      • ES PRO Sterilizing Robot
    • Pharmaceutical Raw material
    • Veterinary instruments
    • Medical device
    • Veterinary
    • Chemical
    • Medicinal bottle
      • Liquid medicinal bottles
      • Cream container
      • Examine apparatus
      • Vagina Applicator
      • Enema bottle
      • Eye drop bottles
      • Solid medicinal bottles
      • Spraying medicinal bottles
      • Oral liquid bottles
    • Health food
    • Cosmetic ingredients

    Links

    Google.comBaidu.com

    LatestPost

    •  Pet Fair Asia 2020 shanghai
      Pet Fair Asia 2020 shanghai
      2020-05-19
    • Interpets Japan 2022
      Interpets Japan 2022
      2022-01-13
    • CASE 4 Outpatient Operating Room H2O2 disinfection
      CASE 4 Outpatient Operating Room H2O2 di
      2020-07-17

    Feedback

    Contact Us

    916419188

    +8613776630851

    info@errason.com

    info@errason.com

    No.1,Building 9, Guanghua East Street,Nanjing City,Jiangsu Province,China

    MOBILE WEBSITE

    Copyright © 2013-2020 Nanjing Errason Biological Company All Rights Reserved.

    • Skype.
    • E-mail
    • Whatsapp
    • Inquiry